Your browser doesn't support javascript.
loading
Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
Arbour, Kathryn C; Kris, Mark G; Riely, Gregory J; Ni, Ai; Beal, Kathryn; Daras, Mariza; Hayes, Sara A; Young, Robert J; Rodriguez, Christopher R; Ahn, Linda; Pao, William; Yu, Helena A.
Afiliação
  • Arbour KC; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kris MG; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Riely GJ; Department of Medicine, Weill Cornell Medicine, New York, New York.
  • Ni A; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Beal K; Department of Medicine, Weill Cornell Medicine, New York, New York.
  • Daras M; Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hayes SA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Young RJ; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rodriguez CR; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ahn L; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Pao W; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Yu HA; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer ; 124(1): 105-109, 2018 Jan 01.
Article em En | MEDLINE | ID: mdl-28940498

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Adenocarcinoma / Inibidores de Proteínas Quinases / Cloridrato de Erlotinib / Neoplasias Pulmonares Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Adenocarcinoma / Inibidores de Proteínas Quinases / Cloridrato de Erlotinib / Neoplasias Pulmonares Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2018 Tipo de documento: Article